Provided by Tiger Trade Technology Pte. Ltd.

Novavax

7.98
+0.01000.13%
Post-market: 8.110.1300+1.63%19:35 EDT
Volume:2.35M
Turnover:18.59M
Market Cap:1.30B
PE:3.09
High:8.04
Open:7.80
Low:7.71
Close:7.97
52wk High:11.97
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:0.58
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.58
EPS(LYR):2.58
ROE:-898.20%
ROA:25.72%
PB:-10.15
PE(LYR):3.09

Loading ...

Under the Radar: Why This 600M Fund Manager Keeps Outperforming Wall Street

Benzinga_recent_news
·
Nov 18, 2025

Novavax price target lowered to $6 from $7 at JPMorgan

TIPRANKS
·
Nov 18, 2025

Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Nov 18, 2025

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 14, 2025

Shah Capital pushes for Novavax sale, warns of proxy fight

Reuters
·
Nov 13, 2025

BRIEF-Shah Capital Pushes For Novavax Sale

Reuters
·
Nov 13, 2025

Shah Capital: Has About 8.3% Shareholding in Novavax

THOMSON REUTERS
·
Nov 13, 2025

Shah Capital: "Novavax Shareholders Will Be Better Served Under the Umbrella of a Larger, Competent Pharma Company"

THOMSON REUTERS
·
Nov 13, 2025

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), Xoma (XOMA) and Novavax (NVAX)

TIPRANKS
·
Nov 13, 2025

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 12, 2025

Stock Track | Novavax Soars 5.06% as B. Riley Maintains Buy Rating Despite Lower Price Target

Stock Track
·
Nov 12, 2025

Stock Track | Novavax Soars 5.06% Despite Price Target Cut as B. Riley Maintains Buy Rating

Stock Track
·
Nov 12, 2025

Novavax price target lowered to $16 from $18 at B. Riley

TIPRANKS
·
Nov 11, 2025

Novavax Inc. Stock Slides 4.4%, Underperforms Peers

Dow Jones
·
Nov 11, 2025

B. Riley Adjusts Price Target on Novavax to $16 From $18, Maintains Buy Rating

MT Newswires Live
·
Nov 10, 2025

Novavax Inc : B. Riley Cuts Target Price to $16 From $18

THOMSON REUTERS
·
Nov 10, 2025

Assessing Novavax (NVAX) Valuation Following Q3 Revenue Beat and Expanded Sanofi Collaboration

Simply Wall St.
·
Nov 10, 2025

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Nov 08, 2025

Novavax delays profitability target with eyes on Sanofi-led launches

Reuters
·
Nov 07, 2025

Novavax Exec Says Co Expects 2026 Adjusted Total Revenue Between $185 Million and $205 Million

THOMSON REUTERS
·
Nov 06, 2025